Thyroid function in children with newly diagnosed type 1 diabetes mellitus

Acta Paediatrica Taiwanica

Volumn 44, Issue 3, 2003, Pages 145-149

  Lin, Chao Hsu ^a   Lee, Yann Jinn ^a,b   Huang, Chi Yu ^a   Kao, Hsin An ^a,b   Shih, Bing Fu ^a   Wang, An Mei ^a   Lo, Fu Sung ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Diabetic ketoacidosis; Nonthyroidal illness; Thyroid function test; Type 1 diabetes

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; EVALUATION; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; FUNCTION TEST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; INFANT; MALE; THYROID FUNCTION TESTS; THYROID GLAND;

EID: 0041321177     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jefferson IG. The clinical approach to thyroid disorders associated with childhood insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 9(Suppl):95-100.
2. Gilani BB, Macgillivray MH, Voorhess ML, Mills BJ, Riley WJ, MacLaren NK. Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children. J Pediatr 1984; 105:218-22.
3. Pittman CS, Suda AK, Chambers JB Jr, Ray GY. Impaired 3,5,3′-triiodothyronine (T3) production in diabetic patients. Metabolism 1979; 28:333-8.
4. Pittman CS, Suda AK, Chamber JB, McDaniel HG, Jay GY, Preston BK. Abnormalities of thyroid hormone turnover in patients with diabetes mellitus before and after insulin therapy. J Clin Endocrinol Metab 1979; 48:854-60.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-97.
6. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 2001; 344:264-9.
7. Alexander CM, Kaptein EM, Lum SM, Spencer CA, Kumar D, Nicoloff JT. Pattern of recovery of thyroid hormone indices associated with treatment of diabetes mellitus. J Clin Endocrinol Metab 1982; 54:362-6.
8. Camacho PM, Dwarkanathan AA. Sick euthyroid syndrome: what to do when thyroid function tests are abnormal in critically ill patients. Postgrad Med 1999; 105:215-9.
9. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illness and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63:1-8.
10. Sterling K, Lazarus JN. The thyroid and its control. Annu Rev Physiol 1977; 39:349-71.
11. Gavin LA, McMahon FA, Moeller M. The mechanism of impaired T3 production from T4 in diabetes. Diabetes 1981; 30:694-9.
12. Docter R, Krenning EP. Role of cellular transport systems in the regulation of thyroid hormone bioactivity. In: Greer, MA, eds. The thyroid gland. New York: Raven Press, 1990: 233-54.
13. th Annual Meeting of the American Diabetes Association, Boston, 1978; 498.
14. Naeije R, Golstein J, Clumeck N, Meinhold H, Wenzel KW, Vanhaelst L. A low T3 syndrome in diabetic ketoacidosis. Clin Endocrinol 1978; 8:467-72.
15. Inada M, Okabe J, Kazama Y, Takayama H, Nakagawa T, Torizuka K. Thyroxine turnover and transport in diabetes mellitus. J Clin Endocrinol Metab 1973; 36:590-7.
16. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxford) 1993; 39:499-518.
17. Oppenheimer JH, Squef R, Surks MI, Hauer H. Binding of thyroxine by serum proteins evaluated by dialysis and electro-phoretic techniques. Alternations in non-thyroidal illnesses. J Clin Invest 1963; 12:1769-82.
18. Helenius T, Liewendahl K. Improved dialysis method for free thyroxin in serum compared with five commercial radioimmunoassays in nonthyroidal illness and subjects with abnormal concentrations of thyroxin-binding globulin. Clin Chem 1983; 29:816-22.
19. Wong TK, Pekary AE, Hoo GS, Bradley ME, Hershman JM. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem 1992; 38:720-4.
20. Binimelis J, Webb SM, Serrano J, et al. Plasma immunoreactive somatostatin is elevated in diabetic ketoacidosis and correlates with plasma non-esterified fatty acid concentration. Diabet Med 1987; 4:221-4.
21. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN. Serum thyroid hormone binding inhibitor in nonthyroidal illnesses. Metabolism 1986; 35:152-9.
22. Woeber KA, Maddux BA. Thyroid hormone binding in nonthyroid illness. Metabolism 1981; 30:412-6.
23. Kaptein EM, Grieb DA, Spencer CA, Wheeler WS, Nicoloff JT. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses. J Clin Endocrinol Metab 1981; 53:764-71.
24. Krenning EP, Docter R, van Toor H, et al. Strategy of thyroid-function testing, a comparative study using TT4, FT41, various FT4 and IRMA-TSH kits. J Endocrinol Invest 1986; 4(Suppl):95-104.
25. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995; 12:622-7.
26. Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987; 33: 1391-6.